HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Perfusion curve f (t) analysis of breast cancer by contrast-enhanced ultrasonography.

AbstractBACKGROUND:
Imaging the perfusion of contrast media in breast tumors may allow improved diagnosing and treating breast cancer.
PURPOSE:
To compare the perfusion curve f (t) characteristics of contrast-enhanced ultrasonography in benign and malignant breast tumors.
MATERIAL AND METHODS:
Patients with breast tumors (n = 87) were evaluated with contrast-enhanced ultrasonography and the perfusion curve f (t) parameters were calculated using Sonoliver(®) software to compare analysis (tumor) and reference (normal) tissue areas. Differences between breast and breast tumors were assessed.
RESULTS:
Compared to benign tumors, malignant tumors had faster enhancement time and a shorter mean transit time (all P values < 0.05). The intensity of the signal was also greater for malignant compared with benign tumors.
CONCLUSION:
Perfusion curve f (t) parameter measurements can distinguish differences in vascular flow between malignant and benign breast tumors and may provide a new quantitative indicator of breast tumor.
AuthorsLiang Guo, Zhi-Gang Liu, Pei-Hua Han, Quan Yuan, Yu He, Jun Li
JournalActa radiologica (Stockholm, Sweden : 1987) (Acta Radiol) Vol. 53 Issue 9 Pg. 981-6 (Nov 01 2012) ISSN: 1600-0455 [Electronic] England
PMID22969089 (Publication Type: Journal Article)
Chemical References
  • Contrast Media
  • Phospholipids
  • contrast agent BR1
  • Sulfur Hexafluoride
Topics
  • Adult
  • Breast Neoplasms (diagnostic imaging)
  • Contrast Media
  • Diagnosis, Differential
  • Female
  • Humans
  • Middle Aged
  • Neovascularization, Pathologic (diagnostic imaging)
  • Phospholipids
  • Retrospective Studies
  • Software
  • Statistics, Nonparametric
  • Sulfur Hexafluoride
  • Ultrasonography, Mammary

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: